Brief: Medexus Pharma Announces Type A Meeting With FDA Granted For Treosulfan
Nov 1 (Reuters) - Medexus Pharmaceuticals Inc MDP.TO :
* MEDEXUS PHARMACEUTICALS ANNOUNCES TYPE A MEETING WITH FDA
GRANTED FOR TREOSULFAN
* MEDEXUS PHARMACEUTICALS - TYPE A MEETING HAS BEEN
SCHEDULED TO
OCCUR ON NOVEMBER 23, 2021
Source text for Eikon: ID:nGNX7JX5kb
Further company coverage: MDP.TO
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Medexus Pharmaceuticals
See all newsCanada's Medexus Q4 revenue misses analyst expectations, net loss widens
Brief: Medexus Pharmaceuticals Q4 Revenue USD 24.652 Million Vs. IBES Estimate USD 25.6 Million
Canada Research Roundup: CAE, Medexus Pharmaceuticals, TCP Energy
Medexus Pharma Q2 revenue misses estimates
Brief: Medexus Pharmaceuticals Q2 Revenue USD 24.741 Million Vs. IBES Estimate USD 25.6 Million